ClinicalTrials.gov
ClinicalTrials.gov Menu

EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00338000
Recruitment Status : Completed
First Posted : June 20, 2006
Last Update Posted : February 1, 2011
Sponsor:
Information provided by:
Janssen Pharmaceutica N.V., Belgium

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2005